GAITHERSBURG, Md. -- An FDA advisory committee has voted 17-0 to recommend approval for the OraQuick In-Home HIV Test. If approved, it will be the first over-the-counter home HIV test. About 2.8 ...
Expansion of the OraQuick® HIV Self-Test to individuals aged 14 and older increases access to vital HIV testing for adolescents, addressing a significant public health need. The approval aligns with ...
BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results